Data di Pubblicazione:
2012
Citazione:
Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy / A. Bersano, S. Lanfranconi, C. Valcarenghi, N. Bresolin, G. Micieli, P. Baron. - In: ACTA NEUROLOGICA SCANDINAVICA. - ISSN 0001-6314. - 126:2(2012 Aug), pp. 77-97.
Abstract:
Fabry disease is a multisystem, X-linked, lysosomal storage disorder caused by a mutation in the GLA gene on chromosome Xq22 resulting in alpha-galactosidase A enzyme (a-Gal A) deficiency. Neurological manifestations other than cerebrovascular accidents include small fibre neuropathy and dysautonomic disorders, which may be the presenting clinical features in a proportion of patients. An atypical disease onset may be misdiagnosed until the emergence of a more typical clinical picture, characterized by chronic renal and cardiac failure. Thus, neurologists should consider Fabry disease in differential diagnosis and provide an appropriate diagnostic work up. This review focuses on central and peripheral nervous system involving available diagnostic tools and diagnostic work up in Fabry disease. It also covers the most recent evidence regarding enzyme replacement therapy.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Fabry disease; neurological aspects; stroke; neuropathy; enzyme replacement therapy
Elenco autori:
A. Bersano, S. Lanfranconi, C. Valcarenghi, N. Bresolin, G. Micieli, P. Baron
Link alla scheda completa: